Journalists came to the SMC to hear about the different tapering strategies studied, which are most effective in reducing the risk of relapse, whether the role of psychological therapy improves ...
Comparative efficacy of zanubrutinib (ZANU) versus fixed-duration acalabrutinib plus venetoclax (AV) for first-line treatment of chronic lymphocytic leukemia (CLL): A matching-adjusted indirect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback